Cabazitaxel in patients with metastatic castration-resistant prostate cancer: safety and quality of life data from the Australian early access program-Reference-Cited by-同舟云学术

Cabazitaxel in patients with metastatic castration-resistant prostate cancer: safety and quality of life data from the Australian early access program

Published:2017-05-10 Issue:6 Volume:13 Page:391-399
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Parente Phillip¹,Ng Siobhan²,Parnis Francis³,Guminski Alex⁴,Gurney Howard⁵

Affiliation:

1. Eastern Health Clinical School, Box Hill Hospital; Monash University; Melbourne VIC Australia

2. St John of God Private Hospital; Subiaco WA Australia

3. Adelaide Cancer Centre; Adelaide SA Australia

4. Royal North Shore Hospital; St Leonards NSW Australia

5. Westmead Hospital; Sydney NSW Australia

Funder

Sanofi-Aventis Australia Pty Ltd

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12679/fullpdf

Reference21 articles.

1. Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer;Parente;Asia Pac J Clin Oncol,2014

2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

3. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points;Tannock;J Clin Oncol,1996

4. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

5. Clinical perspectives: Practical insights from clinical experience with cabazitaxel in Australia;Parente;Asia Pac J Clin Oncol,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial;European Urology Oncology;2024-08

2. Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews;Frontiers in Oncology;2023-09-27

3. Recent advances and future perspectives in the therapeutics of prostate cancer;Experimental Hematology & Oncology;2023-09-22

4. Results from Expanded Access Programs: A Review of Academic Literature;Drugs;2023-05-18

5. Psychosocial Aspects of Living Long Term with Advanced Cancer and Ongoing Systemic Treatment: A Scoping Review;Cancers;2022-08-11